Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8383)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2021 (publication date) through Sep 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang ZH, Liu F, Zhu XR, Suo FY, Jia ZJ, Yao SK. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol 2021; 27(24): 3609-3629 [PMID: 34239273 DOI: 10.3748/wjg.v27.i24.3609] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i24/3609.htm |
| Number | Citing Articles |
| 1 |
Caiguang Liu, Shukai Zhan, Na Li, Tong Tu, Jianming Lin, Manying Li, Minhu Chen, Zhirong Zeng, Xiaojun Zhuang. Bile acid alterations associated with indolent course of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2023; 58(9): 988 doi: 10.1080/00365521.2023.2200518
|
| 2 |
Fan Jingjing, Jin Weilin, Su Shaochen, Khan Aman, Wu Ying, Chen Yanyi, Feng Pengya, Jeon Byong‐Hun, Salama EL‐Sayed, Ling Zhenmin, Liu Pu, Li Xiangkai. A Probiotic Targets Bile Acids Metabolism to Alleviate Ulcerative Colitis by Reducing Conjugated Bile Acids. Molecular Nutrition & Food Research 2024; 68(7) doi: 10.1002/mnfr.202300731
|
| 3 |
Na Li, Cheng Zhao, Pingnan Zhang, Songting Wu, Xiaotan Dou, Saifei Xu, Xiaoqi Zhang, Chunyan Peng, Ying Xie, Shuling Huang, Lin Zhou, Yonghua Shen, Lei Wang, Jinglin Wang, Chenggong Yu. The role of gut microbiota associated metabolites in digestive disorders. Engineered Regeneration 2024; 5(2): 228 doi: 10.1016/j.engreg.2024.04.003
|
| 4 |
Fangjia Hao, Jiamin Zhu, Ning Zhang, Peng He, Qiandan Miao, Yumin Liu, Yu Gao, Xijian Liu, Guoying Deng, Zhong Zhang, Meiqing Feng, Linjing Zhao. Association between gut microbiome and metabolome in mice suffering from acute carbapenem-resistant Escherichia coli infection. Journal of Pharmaceutical and Biomedical Analysis 2022; 215: 114770 doi: 10.1016/j.jpba.2022.114770
|
| 5 |
Miranda Green, Jane A. Foster. Microbes, Microbial Metabolism, and Mucosal Immunity. 2024; : 29 doi: 10.1016/B978-0-323-90144-4.00002-1
|
| 6 |
Lin Yuan, Ying Li, Moutong Chen, Liang Xue, Juan Wang, Yu Ding, Qihui Gu, Jumei Zhang, Hui Zhao, Xinqiang Xie, Qingping Wu. Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives. Applied Microbiology and Biotechnology 2024; 108(1) doi: 10.1007/s00253-024-13007-7
|
| 7 |
Yonghoon Choi, Soo In Choi, Nayoung Kim, Ryoung Hee Nam, Jae Young Jang, Hee Young Na, Cheol Min Shin, Dong Ho Lee, Huitae Min, Yeon-Ran Kim, Yeong-Jae Seok. Effect of Clostridium butyricum on High-Fat Diet-Induced Intestinal Inflammation and Production of Short-Chain Fatty Acids. Digestive Diseases and Sciences 2023; 68(6): 2427 doi: 10.1007/s10620-023-07835-2
|
| 8 |
Pengkui Xia, Tao Hou, Hong Jin, Yaqi Meng, Jing Li, Fuchao Zhan, Fang Geng, Bin Li. A critical review on inflammatory bowel diseases risk factors, dietary nutrients regulation and protective pathways based on gut microbiota during recent 5 years. Critical Reviews in Food Science and Nutrition 2023; : 1 doi: 10.1080/10408398.2023.2204147
|
| 9 |
Shanshan Zhong, Fangxi Liu, Rashid Giniatullin, Jukka Jolkkonen, Yong Li, Zhike Zhou, Xinyu Lin, Chang Liu, Xiuchun Zhang, Zhouyang Liu, Cheng Lv, Qianqian Guo, Chuansheng Zhao. Blockade of CCR5 suppresses paclitaxel-induced peripheral neuropathic pain caused by increased deoxycholic acid. Cell Reports 2023; 42(11): 113386 doi: 10.1016/j.celrep.2023.113386
|
| 10 |
Stefanie Sommersberger, Stefan Gunawan, Tanja Elger, Tanja Fererberger, Johanna Loibl, Muriel Huss, Arne Kandulski, Sabrina Krautbauer, Martina Müller, Gerhard Liebisch, Christa Buechler, Hauke Christian Tews. Altered fecal bile acid composition in active ulcerative colitis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01971-4
|
| 11 |
Kan Gao, Pu Xiu Wang, Xue Mei, Tao Yang, Kai Yu. Untapped potential of gut microbiome for hypertension management. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2356278
|
| 12 |
Sho Kitamoto, Nobuhiko Kamada. The oral-gut axis: a missing piece in the IBD puzzle. Inflammation and Regeneration 2023; 43(1) doi: 10.1186/s41232-023-00304-3
|
| 13 |
Tianyu Yu, Jun Yan, Ruochen Wang, Lei Zhang, Xiake Hu, Jiaxi Xu, Fanni Li, Qi Sun. Integrative Multiomics Profiling Unveils the Protective Function of Ulinastatin against Dextran Sulfate Sodium-Induced Colitis. Antioxidants 2024; 13(2): 214 doi: 10.3390/antiox13020214
|
| 14 |
Jiahui Zheng, Huan Li, Pei Zhang, Shijun Yue, Bingtao Zhai, Junbo Zou, Jiangxue Cheng, Chongbo Zhao, Dongyan Guo, Jing Wang. Paeonol Ameliorates Ulcerative Colitis in Mice by Modulating the Gut Microbiota and Metabolites. Metabolites 2022; 12(10): 956 doi: 10.3390/metabo12100956
|
| 15 |
Yuting Luo, Sai Fu, Yuling Liu, Shasha Kong, Qian Liao, Longfei Lin, Hui Li. Banxia Xiexin decoction modulates gut microbiota and gut microbiota metabolism to alleviate DSS-induced ulcerative colitis. Journal of Ethnopharmacology 2024; 326: 117990 doi: 10.1016/j.jep.2024.117990
|
| 16 |
YangLin Cui, YuMeng Guo, YuChen Kong, GuangYe Zhang. Association between gut microbiota and autoimmune cholestatic liver disease, a Mendelian randomization study. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1348027
|
| 17 |
Daria A. Kuznetsova, Sergey V. Lapin, Irina V. Gubonina. Bile acid dysmetabolism in inflammatory bowel diseases. Almanac of Clinical Medicine 2023; 51(1): 1 doi: 10.18786/2072-0505-2023-51-007
|
| 18 |
Fangjia Hao, Jiamin ZHU, Ning Zhang, Peng He, Qiandan Miao, Yumin Liu, Yu Gao, Xijian Liu, Guoying Deng, Zhong Zhang, Meiqing Feng, Linjing Zhao. Association between Gut Microbiome and Metabolome in Mice Suffering from Acute Carbapenem-Resistant <i>Escherichia coli</i> Infection. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3906496
|
| 19 |
Mengfan Li, Lijiao Yang, Chenlu Mu, Yue Sun, Yu Gu, Danfeng Chen, Tianyu Liu, Hailong Cao. Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives. Computational and Structural Biotechnology Journal 2022; 20: 2402 doi: 10.1016/j.csbj.2022.03.038
|
| 20 |
Jinlan Zhang, Shuhui Sun, Huan Chen, Yifan Feng, Ying Li, Zhengqi Dong. Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1197144
|
| 21 |
Rui Zhou, Yangyi Huang, Congjian Tian, Yong Yang, Zaiqi Zhang, Kai He. Coptis chinensis and Berberine Ameliorate Chronic Ulcerative Colitis: An Integrated Microbiome-Metabolomics Study. The American Journal of Chinese Medicine 2023; 51(08): 2195 doi: 10.1142/S0192415X23500945
|
| 22 |
Andy Acevedo-Román, Natalia Pagán-Zayas, Liz I. Velázquez-Rivera, Aryanne C. Torres-Ventura, Filipa Godoy-Vitorino. Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches. International Journal of Molecular Sciences 2024; 25(17): 9715 doi: 10.3390/ijms25179715
|
| 23 |
Matteo Scanu, Francesca Toto, Valentina Petito, Letizia Masi, Marco Fidaleo, Pierluigi Puca, Valerio Baldelli, Sofia Reddel, Pamela Vernocchi, Giovambattista Pani, Lorenza Putignani, Franco Scaldaferri, Federica Del Chierico. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1366192
|
| 24 |
Jie Fang, Chen-Huan Yu, Xue-Jian Li, Jin-Mei Yao, Zheng-Yu Fang, Soo-Hyun Yoon, Wen-Ying Yu. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.997018
|
| 25 |
Mengjia Zhao, Bixu Wang, Fangmei Zhou, Chengnan Fang, Bingqi Zhu, Mingyuan Zhou, Xiaoqing Ye, Yuchi Chen, Zhishan Ding. Modeling “Two-Hit” Severe Pneumonia in Mice: Pathological Characteristics and Mechanistic Studies. Inflammation 2024; doi: 10.1007/s10753-024-02136-w
|
| 26 |
Yinping Pan, Haojie Zhang, Minghui Li, Tingjing He, Sihao Guo, Liancai Zhu, Jun Tan, Bochu Wang. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2356284
|
| 27 |
Meiling Liu, Siyi Guo, Liang Wang. Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241239580
|
| 28 |
Morgane M. Thibaut, Laure B. Bindels. Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation. Trends in Molecular Medicine 2022; 28(3): 223 doi: 10.1016/j.molmed.2021.12.006
|
| 29 |
Siyu Li, Kan Xu, Yi Cheng, Lu Chen, Ailin Yi, Zhifeng Xiao, Xuefei Zhao, Minjia Chen, Yuting Tian, Wei Meng, Zongyuan Tang, Shuhong Zhou, Guangcong Ruan, Yanling Wei. The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1188455
|
| 30 |
Na Li, Peiguang Ma, Yalan Li, Xuekai Shang, Xinmei Nan, Lei Shi, Xiao Han, Jiajing Liu, Yanfei Hong, Qiuyi Li, Jiaqi Cui, Junxiang Li, Guiying Peng. Gut microbiota-derived 12-ketolithocholic acid suppresses the IL-17A secretion from colonic group 3 innate lymphoid cells to prevent the acute exacerbation of ulcerative colitis. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2290315
|
| 31 |
Wei Niu, Yuelin Dong, Ziwei Fu, Jiajie Lv, Ligui Wang, Zhenhai Zhang, Jiege Huo, Jianming Ju. Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model. International Journal of Biological Macromolecules 2021; 193: 1927 doi: 10.1016/j.ijbiomac.2021.11.024
|
| 32 |
Hongbin Wang, Qiyu Tian, Zhixin Xu, Min Du, Mei-Jun Zhu. Metabolomic profiling for the preventive effects of dietary grape pomace against colorectal cancer. The Journal of Nutritional Biochemistry 2023; 116: 109308 doi: 10.1016/j.jnutbio.2023.109308
|
| 33 |
Lie Zheng. New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(30): 10823-10839 doi: 10.12998/wjcc.v10.i30.10823
|
| 34 |
Bingjie Xiang, Jun Hu, Min Zhang, Min Zhi. The involvement of oral bacteria in inflammatory bowel disease. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goae076
|
| 35 |
Dickson Kofi Wiredu Ocansey, Sanhua Hang, Xinyi Yuan, Hua Qian, Mengjiao Zhou, Chinasa Valerie Olovo, Xu Zhang, Fei Mao. The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2176118
|
| 36 |
Phurpa Wangchuk, Karma Yeshi, Alex Loukas. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends in Pharmacological Sciences 2024; doi: 10.1016/j.tips.2024.08.003
|
| 37 |
Abdulrahman Mujalli, Wesam F. Farrash, Kawthar S. Alghamdi, Ahmad A. Obaid. Metabolite Alterations in Autoimmune Diseases: A Systematic Review of Metabolomics Studies. Metabolites 2023; 13(9): 987 doi: 10.3390/metabo13090987
|
| 38 |
Jing Li, Ai-hua Zhang, Fang-fang Wu, Xi-jun Wang. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.841552
|
| 39 |
Chi Zhang, Yujia Hu, Yi Yuan, Jingke Guo, Henian Li, Qiaoling Li, Shutao Liu. Liposome-embedded SOD attenuated DSS-induced ulcerative colitis in mice by ameliorating oxidative stress and intestinal barrier dysfunction. Food & Function 2023; 14(9): 4392 doi: 10.1039/D2FO03312G
|
| 40 |
Rui Sun, Jingjing Jiang, Ling Yang, Lu Chen, Hong Chen, Walter Fries. Alterations of Serum Bile Acid Profile in Patients with Crohn’s Disease. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/1680008
|
| 41 |
Guanzhou Zhou, Nana Zhang, Ke Meng, Fei Pan. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1001623
|
| 42 |
Byron J. Smith, Yvette Piceno, Martin Zydek, Bing Zhang, Lara Aboud Syriani, Jonathan P. Terdiman, Zain Kassam, Averil Ma, Susan V. Lynch, Katherine S. Pollard, Najwa El-Nachef. Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-09307-5
|
| 43 |
Wen-Wen Cheng, Bao-Hong Liu, Xiao-Ting Hou, Huan Meng, Dan Wang, Cheng-Hao Zhang, Shuo Yuan, Qing-Gao Zhang. Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes. The American Journal of Chinese Medicine 2024; : 1 doi: 10.1142/S0192415X24500514
|
| 44 |
Dan Liu, Ran Zhao, Yajing Wu, Yunhong Wang, Rongping Yang, Xiumei Ke. Variation in the Efficacy of Anti-Ulcerative Colitis Treatments Reveals the Conflict Between Precipitating Compatibility of Traditional Chinese Medicine and Modern Technology: A Case of Scutellaria-Coptis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.819851
|
| 45 |
Wenwen Li, Yun Zhang, Quyi Wang, Yu Wang, Yuwen Fan, Erxin Shang, Shu Jiang, Jinao Duan. 6-Gingerol ameliorates ulcerative colitis by inhibiting ferroptosis based on the integrative analysis of plasma metabolomics and network pharmacology. Food & Function 2024; 15(11): 6054 doi: 10.1039/D4FO00952E
|
| 46 |
Min Yang, Yu Gu, Lingfeng Li, Tianyu Liu, Xueli Song, Yue Sun, Xiaocang Cao, Bangmao Wang, Kui Jiang, Hailong Cao. Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients 2021; 13(9): 3143 doi: 10.3390/nu13093143
|
| 47 |
Serena Onwuka, Laura Bravo-Merodio, Georgios V. Gkoutos, Animesh Acharjee. Explainable AI-prioritized plasma and fecal metabolites in inflammatory bowel disease and their dietary associations. iScience 2024; 27(7): 110298 doi: 10.1016/j.isci.2024.110298
|
| 48 |
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, Piero Portincasa. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Internal and Emergency Medicine 2023; 18(8): 2181 doi: 10.1007/s11739-023-03343-3
|
| 49 |
Fangfei Xiao, Fang Dong, Xiaolu Li, Youran Li, Guangjun Yu, Zhanju Liu, Yizhong Wang, Ting Zhang. Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.902337
|
| 50 |
Hitomi Kubota, Michiyasu Ishizawa, Makoto Kodama, Yoshihiro Nagase, Shigeaki Kato, Makoto Makishima, Kenichi Sakurai. Vitamin D Receptor Mediates Attenuating Effect of Lithocholic Acid on Dextran Sulfate Sodium Induced Colitis in Mice. International Journal of Molecular Sciences 2023; 24(4): 3517 doi: 10.3390/ijms24043517
|
| 51 |
Wang Haiou, Li Jinyou, Huang Wenkang, Ye Yiping, Gao Lijuan. The regulation of intestinal microbiota and the intervention of Chinese herbal medicine in the treatment of ulcerative colitis. Pharmacological Research - Modern Chinese Medicine 2024; 10: 100356 doi: 10.1016/j.prmcm.2024.100356
|
| 52 |
Youping Liu, Meng Yang, Zhiling Ran, Junxia Wang, Wujie Ma, Qiaoni Sheng. Effect of Different Doses of Vitamin D on the Intestinal Flora of Babies with Eczema: An Experimental Study. Life 2022; 12(9): 1409 doi: 10.3390/life12091409
|
| 53 |
Gabrio Bassotti, Alessandro Fruganti, Fabrizio Stracci, Pierfrancesco Marconi, Katia Fettucciari. Cytotoxic synergism of <i>Clostridioides difficile</i> toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases. World Journal of Gastroenterology 2023; 29(4): 582-596 doi: 10.3748/wjg.v29.i4.582
|
| 54 |
Nathan Calzadilla, Shane M. Comiskey, Pradeep K. Dudeja, Seema Saksena, Ravinder K. Gill, Waddah A. Alrefai. Bile acids as inflammatory mediators and modulators of intestinal permeability. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1021924
|
| 55 |
Hao Cheng, Dandan Zhang, Jing Wu, Juan Liu, Yuzhu Tan, Wuwen Feng, Cheng Peng. Atractylodes macrocephala Koidz. volatile oil relieves acute ulcerative colitis via regulating gut microbiota and gut microbiota metabolism. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1127785
|
| 56 |
Yulia Shulpekova, Maria Zharkova, Pyotr Tkachenko, Igor Tikhonov, Alexander Stepanov, Alexandra Synitsyna, Alexander Izotov, Tatyana Butkova, Nadezhda Shulpekova, Natalia Lapina, Vladimir Nechaev, Svetlana Kardasheva, Alexey Okhlobystin, Vladimir Ivashkin. The Role of Bile Acids in the Human Body and in the Development of Diseases. Molecules 2022; 27(11): 3401 doi: 10.3390/molecules27113401
|
| 57 |
Yunlong Dong, Hongjie Song, Andrew J. Holmes, Jiabao Yan, Cuiru Ren, Ying Zhang, Wei Zhao, Jianhui Yuan, Yuyang Cheng, David Raubenheimer, Zhenwei Cui. Normal diet ameliorates obesity more safely and effectively than ketogenic diet does in high-fat diet-induced obesity mouse based on gut microbiota and lipid metabolism. International Journal of Food Sciences and Nutrition 2023; 74(5): 589 doi: 10.1080/09637486.2023.2235899
|
| 58 |
Hao Cheng, Juan Liu, Dandan Zhang, Jing Wang, Yuzhu Tan, Wuwen Feng, Cheng Peng. Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.817600
|
| 59 |
Ipsita Mohanty, Helena Mannochio-Russo, Joshua V. Schweer, Yasin El Abiead, Wout Bittremieux, Shipei Xing, Robin Schmid, Simone Zuffa, Felipe Vasquez, Valentina B. Muti, Jasmine Zemlin, Omar E. Tovar-Herrera, Sarah Moraïs, Dhimant Desai, Shantu Amin, Imhoi Koo, Christoph W. Turck, Itzhak Mizrahi, Penny M. Kris-Etherton, Kristina S. Petersen, Jennifer A. Fleming, Tao Huan, Andrew D. Patterson, Dionicio Siegel, Lee R. Hagey, Mingxun Wang, Allegra T. Aron, Pieter C. Dorrestein. The underappreciated diversity of bile acid modifications. Cell 2024; 187(7): 1801 doi: 10.1016/j.cell.2024.02.019
|
| 60 |
Jing Wang, Mei He, Ming Yang, Xiaopeng Ai. Gut microbiota as a key regulator of intestinal mucosal immunity. Life Sciences 2024; 345: 122612 doi: 10.1016/j.lfs.2024.122612
|
| 61 |
Dinesh Mohan Swamikkannu, Santhosha Dasarapu, Rajendra Prasad Velivela Siva, Javali Nallam, Satvika Pabba. The gut-liver nexus: exploring gut microbiota dysbiosis in non-alcoholic fatty liver disease and its therapeutic implications. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00331-w
|
| 62 |
Xiong-Quan Long, Ming-Zhu Liu, Zi-Hao Liu, Lv-Zhou Xia, Shi-Peng Lu, Xiao-Ping Xu, Ming-Hao Wu. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease. World Journal of Gastroenterology 2023; 29(27): 4252-4270 doi: 10.3748/wjg.v29.i27.4252
Abstract(564) |
Core Tip(479) |
Full Article(HTML)(2967)
|
Full Article with Cover (PDF)-5511K(101)
|
Full Article (Word)-1914K(46)
|
Audio-589K(3)
|
Peer-Review Report-261K(54)
|
Answering Reviewers-93K(55)
|
Full Article (PDF)-4399K(269)
|
Full Article (XML)-388K(51)
|
Times Cited (6)
|
Total Visits (6912)
|
Open
|
| 63 |
Xingqiang Huang, Xueyi Chen, Guowei Wan, Dandan Yang, Dongqiang Zhu, Linqian Jia, Jinping Zheng. Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma——based on microbiomics and metabolomics. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11982-8
|
| 64 |
Sho Kitamoto, Nobuhiko Kamada. Untangling the oral–gut axis in the pathogenesis of intestinal inflammation. International Immunology 2022; 34(9): 485 doi: 10.1093/intimm/dxac027
|
| 65 |
Jeanne A. Ishimwe, Thanvi Dola, Lale A. Ertuglu, Annet Kirabo. Bile acids and salt-sensitive hypertension: a role of the gut-liver axis. American Journal of Physiology-Heart and Circulatory Physiology 2022; 322(4): H636 doi: 10.1152/ajpheart.00027.2022
|
| 66 |
Yayun Xu, Hui Jing, Jianfa Wang, Shilong Zhang, Qimeng Chang, Zhanming Li, Xubo Wu, Ziping Zhang. Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.800604
|
| 67 |
Feng Xu, Hongmei Wu, Xiangpei Wang. Exploring the role and mechanism of herbal pair fanbaicao-daxueteng in the treatment of UC based on GEO chip and bioinformatics. Proceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science 2023; : 1157 doi: 10.1145/3644116.3644313
|
| 68 |
Sithara Vivek, You Shan Shen, Weihua Guan, Guillaume Onyeaghala, Mosunmoluwa Oyenuga, Christopher Staley, Amy B. Karger, Anna E. Prizment, Bharat Thyagarajan. Association between Circulating T Cells and the Gut Microbiome in Healthy Individuals: Findings from a Pilot Study. International Journal of Molecular Sciences 2024; 25(13): 6831 doi: 10.3390/ijms25136831
|
| 69 |
Xiaoyu Cai, Zhi Li, Yao Yao, Yongquan Zheng, Meng Zhang, Yiqing Ye. Glycolithocholic acid increases the frequency of circulating Tregs through constitutive androstane receptor to alleviate postmenopausal osteoporosis. Biochemical Pharmacology 2024; 219: 115951 doi: 10.1016/j.bcp.2023.115951
|
| 70 |
Fangle Liu, Yufeng Yao, Qian Wang, Fengxue Zhang, Meiqi Wang, Chenchen Zhu, Chaozhan Lin. Nigakinone alleviates DSS‐induced experimental colitis via regulating bile acid profile and FXR/NLRP3 signaling pathways. Phytotherapy Research 2023; 37(1): 15 doi: 10.1002/ptr.7588
|
| 71 |
Juan Hernandez, Soufien Rhimi, Aicha Kriaa, Vincent Mariaule, Houda Boudaya, Amandine Drut, Amin Jablaoui, Héla Mkaouar, Amel Saidi, Vincent Biourge, Mohamed Ali Borgi, Moez Rhimi, Emmanuelle Maguin. Domestic Environment and Gut Microbiota: Lessons from Pet Dogs. Microorganisms 2022; 10(5): 949 doi: 10.3390/microorganisms10050949
|
| 72 |
Tadakuni Monma, Junichi Iwamoto, Hajime Ueda, Makoto Tamamushi, Fumio Kakizaki, Naoki Konishi, Shoichiro Yara, Teruo Miyazaki, Takeshi Hirayama, Tadashi Ikegami, Akira Honda. Evaluation of gut dysbiosis using serum and fecal bile acid profiles. World Journal of Clinical Cases 2022; 10(34): 12484-12493 doi: 10.12998/wjcc.v10.i34.12484
|